The contraceptive market is anticipated to be valued at US$ 19.79 billion in 2024 and registering a CAGR of 5.5% from 2024 to 2034. The market is foreseen to reach US$ 33.79 billion by 2034.
Contraception, which involves preventing pregnancy using drugs or devices, is expanding due to factors such as family planning, higher education, health issues, and increased awareness of modern contraception.
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 19.79 billion |
| Market Value for 2034 | US$ 33.79 billion |
| Market Forecast CAGR for 2024 to 2034 | 5.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The contraceptive market has historically developed at a CAGR of 3.9%. However, sales have advanced at a trivial pace, displaying a CAGR of 5.5% from 2024 to 2034.
| Attributes | Details |
|---|---|
| Market Historical CAGR for 2019 to 2023 | 3.90% |
Long-term use of birth control medications can cause side effects such as bleeding, headaches, nausea, and weight gain. The low adoption of contraception in developing countries is due to a lack of awareness and social taboos.
Alternative methods like condoms and IUDs, which are effective without side effects, also contribute to the low adoption rate of these drugs. Healthcare providers and facility managers face challenges integrating human rights into contraception services, ensuring high quality, autonomy, and respectful care.
The global pandemic has particularly impacted market growth, leading to a drop in device sales due to strict lockdown regulations. The family planning industry has been significantly impacted by the global pandemic, causing a slow recovery due to a lack of raw materials, workforce, and new consignments.
Clinical trials are anticipated to introduce new contraception pills and gels to address new laws and limitations on current birth control procedures. The focus is on developing a non-hormonal pill to expand men's birth control options.
Principal Consultant
Widespread Demand for Wearable Pregnancy Devices
Adoption of Hormonal Contraception Simplifies the Pregnancy Scare
Rise in Government Initiatives for Promoting Access to Family Planning
The following part offers an in-depth analysis of segments of the contraceptive market. The demand for drugs is significant, whereas the need for female contraceptive is anticipated to increase in 2024.
| Attributes | Details |
|---|---|
| Top Product Type | Drug |
| Market share in 2024 | 41.50% |
The demand for contraceptive drugs is experiencing a 41.50% market share growth in 2024 due to augmented family planning and contraception efforts.
| Attributes | Details |
|---|---|
| Top Gender | Female |
| Market share in 2024 | 74.70% |
The demand for contraceptives for female patients is augmented, with a market share of 74.70% in 2024. Because female contraception techniques are more effective at preventing conception than male contraception, they are more widely used.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on the statistical data, industries in China and Germany are developing relatively in the upcoming decade. Simultaneously, the contraception industry in the United States and India is hitting the roof. The contraceptive sector in the ANZ region is anticipated to climb gradually in the upcoming decade.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| United States | 5.80% |
| Germany | 5.50% |
| China | 6.10% |
| India | 5.80% |
| Australia and New Zealand | 5.10% |
The United States is anticipated to hold a CAGR of 5.8% from 2024 to 2034 in the contraceptive market.
In the United States, abstinence-only sex education is the primary form of sexual education, promoting abstinence from sex outside marriage or premarital sex in 39 states and the District of Columbia. However, this often excludes essential birth control measures and safe sex practices, contributing to an increase in teenage pregnancy rates due to the lack of comprehensive sex education.
Lack of accurate sex education in schools can hinder the adoption of products like female condoms, hindering market growth in the United States. Youth may remain unaware of these products, leading to their inability to use them. Therefore, it is essential to prioritize comprehensive sexual education in schools to empower young individuals to make decisions about their sexual health.
Demand for contraception devices in Germany is estimated to develop at a CAGR of 5.5%, with firms developing innovative solutions for birth control.
Germany's public health insurance is highly profitable, covering various health services, including birth control for women under 22. This provision ensures affordable and reliable contraception, allowing young women to make decisions about their reproductive health.
Germany's high prevalence of contraception use is attributed to its exceptional access to online information and average availability of contraception supplies, with most women using some form of birth control.
Germany achieved a 75.1 score in the 2020 European Contraception Policy Atlas, highlighting its commitment to providing comprehensive and accessible reproductive health services to its citizens.
China is on the brink of a significant market expansion in contraceptive devices and drugs, with a projected CAGR of 6.1% from 2024 to 2034.
Oral contraception, also known as birth control tablets or "the pill," is a popular form of contraception in China. These synthetic hormones, typically estrogen and progestin, limit ovulation and egg release, improving women's reproductive health and providing a safe and practical method of pregnancy avoidance.
China's oral contraceptives are highly effective, with less than one in 100 women experiencing unintentional pregnancy within a year of regular use, demonstrating their widespread use in the country.
China's oral contraception demand is increasing due to increased awareness, women's employment, STIs, LARC use, and Internet pharmacies.
The pandemic has impacted women's access to contraception and abortion services in the ANZ region, leading to increased unintended pregnancies and a rise in contraception demand. The demand for contraception solutions in Australia and New Zealand is anticipated to register a CAGR of 5.1% through 2034.
The contraceptive market growth is primarily compelled by increasing sexually transmitted disease cases and Australia's government's and organizations' initiatives on contraception device use.
The prevalence of sexually transmitted diseases, including HIV, Gonorrhoea, Hepatitis, HPV, and PID, is predicted to boost demand for contraception devices, particularly in Australia and New Zealand.
The demand for contraception methods in India is foreseen to experience a CAGR of 5.8% from 2024 to 2034.
India's population growth boosts family planning and contraception demand, highlighting the importance of sexual and reproductive health, particularly among women, leading to increased demand for these services.
The Indian government has implemented various programs, including the National Family Planning Programme, to promote family planning and increase access to contraception methods.
Private companies are investing in contraception research and development. For instance, Reckitt Benckiser Group sold its contraception division to Mankind Pharma for US$ 13 million in March 2023, providing access to various contraception, including the Durex brand.
The market is a competitive and rapidly evolving industry. Key players focus on diverse techniques to stay ahead of the competition and augment their presence in the market. Effective strategies are to acquire or collaborate with companies to improve their product portfolio and market penetration.
Companies, in addition to acquisitions and collaborations, prioritize gaining FDA approvals to ensure the safety and effectiveness of their products, giving them a competitive edge over competitors who may not have received the necessary approvals.
The leading companies are well known for their innovative products and commitment to providing safe and effective contraception to women globally. By leveraging these key strategies, they are able to stay ahead of the competition and continue to grow their businesses in a rapidly evolving market.
Recent Developments in the Contraceptive Market
The market is valued at US$ 19.79 billion in 2024.
The market is set to be valued at US$ 33.79 billion by 2034.
In the United States, demand for contraceptive solutions is anticipated to develop a CAGR of 5.8% by 2034.
The market is to register a CAGR of 5.5% from 2024 to 2034.
Contraceptive drugs are anticipated to acquire a 41.5% market share in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Drugs 5.3.1.1. Oral Contraceptive Pills 5.3.1.2. Injectable Contraceptives 5.3.1.3. Topical Contraceptives 5.3.2. Devices 5.3.2.1. Condoms 5.3.2.2. Diaphragms 5.3.2.3. Contraceptive Sponges 5.3.2.4. Vaginal Rings 5.3.2.5. Cervical Cap 5.3.2.6. Subdermal Implants 5.3.2.7. Intra-Uterine Devices 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Gender 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Gender, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Gender, 2024 to 2034 6.3.1. Female 6.3.2. Male 6.4. Y-o-Y Growth Trend Analysis By Gender, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Gender, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Distribution Channel, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Distribution Channel, 2024 to 2034 7.3.1. Institutional Sales 7.3.1.1. Hospitals 7.3.1.2. Specialty Clinics 7.3.2. Retail Sales 7.3.2.1. Retail Pharmacy 7.3.2.2. Drug Stores 7.3.2.3. Supermarkets/ Hypermarkets 7.3.3. Online Sales 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Gender 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Gender 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Gender 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Gender 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Gender 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Gender 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Gender 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Gender 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Gender 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Gender 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Gender 14.2.4. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Gender 14.3.4. By Distribution Channel 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Gender 15.2.4. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Gender 15.3.4. By Distribution Channel 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product 16.1.2.2. By Gender 16.1.2.3. By Distribution Channel 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product 16.2.2.2. By Gender 16.2.2.3. By Distribution Channel 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product 16.3.2.2. By Gender 16.3.2.3. By Distribution Channel 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product 16.4.2.2. By Gender 16.4.2.3. By Distribution Channel 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product 16.5.2.2. By Gender 16.5.2.3. By Distribution Channel 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product 16.6.2.2. By Gender 16.6.2.3. By Distribution Channel 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product 16.7.2.2. By Gender 16.7.2.3. By Distribution Channel 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product 16.8.2.2. By Gender 16.8.2.3. By Distribution Channel 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product 16.9.2.2. By Gender 16.9.2.3. By Distribution Channel 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product 16.10.2.2. By Gender 16.10.2.3. By Distribution Channel 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product 16.11.2.2. By Gender 16.11.2.3. By Distribution Channel 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product 16.12.2.2. By Gender 16.12.2.3. By Distribution Channel 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product 16.13.2.2. By Gender 16.13.2.3. By Distribution Channel 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product 16.14.2.2. By Gender 16.14.2.3. By Distribution Channel 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product 16.15.2.2. By Gender 16.15.2.3. By Distribution Channel 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product 16.16.2.2. By Gender 16.16.2.3. By Distribution Channel 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product 16.17.2.2. By Gender 16.17.2.3. By Distribution Channel 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product 16.18.2.2. By Gender 16.18.2.3. By Distribution Channel 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product 16.19.2.2. By Gender 16.19.2.3. By Distribution Channel 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product 16.20.2.2. By Gender 16.20.2.3. By Distribution Channel 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product 16.21.2.2. By Gender 16.21.2.3. By Distribution Channel 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product 16.22.2.2. By Gender 16.22.2.3. By Distribution Channel 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product 16.23.2.2. By Gender 16.23.2.3. By Distribution Channel 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Gender 17.3.4. By Distribution Channel 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Bayer AG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Pfizer Inc 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Janssen Global Services, LLC 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Teva Pharmaceutical Industries Ltd. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Merck & Co., Inc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Mylan N.V. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Allergan Plc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Reckitt Benckiser Group plc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Veru Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Cooper Surgical, Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Contraceptive Market
